MRBK:NASDAQMeridian Corporation Analysis
Data as of 2026-05-31 - not real-time
$17.98
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Meridian Corporation (MRBK) trades at a price well below its industry peers, with a trailing PE around half of the sector average and a price‑to‑book just above parity, suggesting a notable valuation cushion. The 3.1% dividend yield combined with a modest payout ratio under 30% points to a sustainable income stream, while revenue growth of roughly 4% signals steady top‑line expansion.
Technically, the stock sits just above its near‑term support of $16.87, the 20‑day SMA sits below the current price, and the MACD histogram has turned positive, indicating emerging bullish momentum despite a neutral RSI near 50. However, recent headlines flag multiple shareholder‑rights investigations, adding a layer of legal and reputational risk that could temper upside expectations.
Technically, the stock sits just above its near‑term support of $16.87, the 20‑day SMA sits below the current price, and the MACD histogram has turned positive, indicating emerging bullish momentum despite a neutral RSI near 50. However, recent headlines flag multiple shareholder‑rights investigations, adding a layer of legal and reputational risk that could temper upside expectations.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above key support
- Positive MACD histogram suggesting early bullish shift
- Ongoing litigation investigations creating near‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued valuation metrics relative to peers
- Attractive dividend yield with low payout ratio
- Consistent earnings growth and improving forward PE
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustainable dividend and solid balance‑sheet fundamentals
- Potential regulatory and legal headwinds from shareholder lawsuits
- Stable regional banking franchise with modest growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth3.90%
Profit Margin19.05%
P/E Ratio9.7
ROE11.47%
ROA0.84%
P/B Ratio1.1
Op. Cash Flow$9.0M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI48.3
Support$16.87
Resistance$19.00
MA 20$17.68
MA 50$18.79
MA 200$17.29
MACDBullish
VolumeStable
Fear & Greed Index94.07
Valuation
Target Price$22.00
Upside/Downside22.36%
GradeUndervalued
TypeValue
Dividend Yield3.11%
Risk Assessment
Beta0.72
Volatility40.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.